IDERA PHARMACEUTICALS INC's ticker is and the CUSIP is 45168K956. A total of 3 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $131,000 | -5.8% | 99,100 | +31.6% | 0.00% | 0.0% |
| Q1 2018 | $139,000 | -45.9% | 75,300 | -38.1% | 0.00% | -50.0% |
| Q4 2017 | $257,000 | +46.0% | 121,700 | +54.4% | 0.00% | 0.0% |
| Q3 2017 | $176,000 | +22.2% | 78,800 | -6.0% | 0.00% | +100.0% |
| Q2 2017 | $144,000 | -61.7% | 83,800 | -44.9% | 0.00% | -75.0% |
| Q1 2017 | $376,000 | +47.5% | 152,100 | -10.4% | 0.00% | +100.0% |
| Q4 2016 | $255,000 | +2.0% | 169,700 | +73.7% | 0.00% | -33.3% |
| Q3 2016 | $250,000 | +61.3% | 97,700 | -3.3% | 0.00% | +50.0% |
| Q2 2016 | $155,000 | -43.2% | 101,000 | -26.8% | 0.00% | -50.0% |
| Q1 2016 | $273,000 | -32.3% | 138,000 | +5.9% | 0.00% | -20.0% |
| Q4 2015 | $403,000 | +36.6% | 130,300 | +47.7% | 0.01% | +25.0% |
| Q3 2015 | $295,000 | -52.4% | 88,200 | -47.2% | 0.00% | -55.6% |
| Q2 2015 | $620,000 | +119.9% | 167,000 | +120.0% | 0.01% | +125.0% |
| Q1 2015 | $282,000 | +28.2% | 75,900 | +52.1% | 0.00% | +33.3% |
| Q4 2014 | $220,000 | -64.9% | 49,900 | -81.8% | 0.00% | -70.0% |
| Q3 2014 | $627,000 | -63.5% | 273,700 | -53.7% | 0.01% | -61.5% |
| Q2 2014 | $1,716,000 | -13.5% | 591,700 | +21.7% | 0.03% | -21.2% |
| Q1 2014 | $1,983,000 | – | 486,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 138,000 | $273,000 | 0.00% |